USC Clinical Trials Office

Serving patients, researchers and sponsors by expediting clinical trials for novel and promising therapies

DocuSign Electronic Signatures Now Accepted by DCG and CTO

By Sara Katrdzhyan


To improve processing and study start-up timelines for all research contracting, the DCG and CTO have adopted DocuSign as our electronic signature system. DocuSign is a market leader in e-signature systems. After surveying our sponsors and academic partners, many are using or accept DocuSign as an alternative to their traditional execution process. The expected benefits are:

  • Improving the speed of study start-up
  • Creating improved visibility into document execution status
  • Freeing-up resources within CTO and DCG department staff and sponsors by automating a previously paper-based process
  • DocuSign is considered to have the highest security, legal enforceability and compliance standards of available signature systems
  • Accessible on mobile devices for review and signing of documents

If you have any questions, please contact your DCG Contract Officer or CTO Contract Manager.